Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials

Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer’s disease: a network meta-analysis of 41 randomized controlled trials

Abstract Background Cholinesterase inhibitors and memantine have been approved for management of Alzheimer’s disease (AD), but there has been no consensus about the choice of various types and doses of drugs at different stages. Hence, we compared and ranked the efficacy and tolerability of these av...

Full description

Bibliographic Details
Main Authors: Kai-Xin Dou, Meng-Shan Tan, Chen-Chen Tan, Xi-Peng Cao, Xiao-He Hou, Qi-Hao Guo, Lan Tan, Vincent Mok, Jin-Tai Yu
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Cholinesterase inhibitors
Memantine
Network meta-analysis
Online Access:http://link.springer.com/article/10.1186/s13195-018-0457-9

Internet

http://link.springer.com/article/10.1186/s13195-018-0457-9

Similar Items